Sistema endocanabinoide: modificando los factores de riesgo cardiovascular
Feliciano Alfonso, John Edwin; Mendivil Anaya, Carlos Olimpo; Sierra Ariza, Iván Dario.
Rev. Fac. Med. (Bogotá)
; 54(4): 269-282, oct.-dic. 2006. ilus
Artículo en Español | LILACS | ID: lil-440756
Documentos relacionados
Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS.
The Endocannabinoid System in Caenorhabditis elegans.
A Novel Cryo-EM Structure Enables Development of Selective Cannabinoid Receptor Drugs.
Crystal Structure of the Human Cannabinoid Receptor CB2.
Reliable prediction of cannabinoid receptor 2 ligand by machine learning based on combined fingerprints.
Prediction of Orthosteric and Allosteric Regulations on Cannabinoid Receptors Using Supervised Machine Learning Classifiers.
Cannabinoid Receptors in Myocardial Injury: A Brother Born to Rival.
Structure-Based Identification of Organoruthenium Compounds as Nanomolar Antagonists of Cannabinoid Receptors.
Endocannabinoid signaling in the central nervous system.
An enquiry to the role of CB1 receptors in neurodegeneration.